Table 2. Weight and BMI measurements before and during the pandemic.
Before pandemic | During pandemic | Difference | ||||||||
Measurements | Mean±SD | Median | Q1-Q3 | Mean±SD | Median | Q1-Q3 | Mean±SD | Median | Q1-Q3 | p |
FMS group | ||||||||||
Weight (kg) | 71.4±12.6 | 70 | 63-79 | 72.3±12.5 | 70 | 64-80 | 0.9±3.1 | 0 | 0-2 | <0.001 |
BMI (kg/cm2) | 26.7±4.7 | 26.1 | 23.44-29 | 27.0±4.6 | 26.56 | 23.6-29.3 | 0.3±1.3 | 0 | 0-0.8 | <0.001 |
CLBP group | ||||||||||
Weight (kg) | 76.1±14.1 | 75 | 65.5-85 | 76.6±14.0 | 76 | 23.6-29.3 | 0.5±3.5 | 12 | 0-2 | 0.001 |
BMI (kg/cm2) | 26.8±4.4 | 26.4 | 23.5-29.4 | 27.0±4.4 | 26.81 | 23.9-30 | 0.2±1.1 | 0 | 0-0.7 | <0.001 |
Healthy control group | ||||||||||
Weight (kg) | 68.5±13.2 | 66 | 58.5-78 | 69.0±13.6 | 67 | 59-78 | 0.5±2.9 | 20 | 0-1 | <0.001 |
BMI (kg/cm2) | 24.6±4.1 | 24 | 21.6-27 | 24.8±4.3 | 24.03 | 21.9-27 | 0.2±1.0 | 0 | 0-0.48 | <0.001 |
BMI: Body mass index; SD: Standard deviation; FMS: Fibromyalgia syndrome; CLBP: Chronic low back pain; Wilcoxon signed rank test. |